UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2004
or
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 0-21229
Stericycle, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 36-3640402 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification Number) |
28161 North Keith Drive
Lake Forest, Illinois 60045
(Address of principal executive offices including zip code)
(847) 367-5910
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). YES x NO ¨
As of April 30, 2004 there were 43,432,793 shares of the Registrants Common Stock outstanding.
Table of Contents
2
PART I FINANCIAL INFORMATION
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
March 31, 2004 |
December 31, 2003 | |||||
(unaudited) | ||||||
ASSETS | ||||||
Current assets: |
||||||
Cash and cash equivalents |
$ | 3,132 | $ | 7,240 | ||
Short-term investments |
334 | 641 | ||||
Accounts receivable, less allowance for doubtful accounts of $3,601 in 2004 and $4,149 in 2003 |
58,978 | 59,711 | ||||
Parts and supplies |
2,946 | 3,244 | ||||
Prepaid expenses |
4,694 | 7,339 | ||||
Notes receivable |
3,423 | 2,223 | ||||
Deferred tax asset |
9,504 | 12,345 | ||||
Other |
1,379 | 4,994 | ||||
Total current assets |
84,390 | 97,737 | ||||
Property, plant and equipment, net |
97,629 | 96,562 | ||||
Other assets: |
||||||
Goodwill, net |
476,396 | 464,946 | ||||
Intangible assets, less accumulated amortization of $6,084 in 2004 and $5,459 in 2003 |
32,212 | 31,642 | ||||
Notes receivable |
9,617 | 7,717 | ||||
Other |
7,401 | 8,858 | ||||
Total other assets |
525,626 | 513,163 | ||||
Total assets |
$ | 707,645 | $ | 707,462 | ||
LIABILITIES AND SHAREHOLDERS EQUITY | ||||||
Current liabilities: |
||||||
Current portion of long term debt |
$ | 5,332 | $ | 4,830 | ||
Accounts payable |
9,587 | 15,741 | ||||
Accrued liabilities |
44,599 | 43,436 | ||||
Deferred revenue |
7,624 | 4,987 | ||||
Total current liabilities |
67,142 | 68,994 | ||||
Long-term debt, net of current portion |
148,924 | 163,016 | ||||
Deferred income taxes |
38,668 | 42,277 | ||||
Other liabilities |
4,113 | 4,411 | ||||
Redeemable preferred stock: |
||||||
Series A convertible preferred stock (par value $.01 share, 75,000 shares authorized, 12,348 outstanding in 2004 and 22,799 outstanding in 2003, liquidation preference of $13,438 at March 31, 2004 and $24,814 at December 31, 2003) |
9,569 | 20,944 | ||||
Common shareholders equity: |
||||||
Common stock (par value $.01 per share, 80,000,000 shares authorized, 43,341,018 issued and outstanding in in 2004, 41,868,515 issued and outstanding in 2003) |
434 | 420 | ||||
Additional paid-in capital |
303,096 | 290,631 | ||||
Accumulated other comprehensive income |
336 | 530 | ||||
Retained earnings |
135,363 | 116,239 | ||||
Total shareholders equity |
439,229 | 407,820 | ||||
Total liabilities and shareholders equity |
$ | 707,645 | $ | 707,462 | ||
The accompanying notes are an integral part of these financial statements
3
STERICYCLE, INC. AND SUBSIDIARIES CONDENSED
CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(unaudited)
Three Months Ended March 31, |
||||||||
2004 |
2003 |
|||||||
Revenues |
$ | 117,556 | $ | 112,311 | ||||
Costs and expenses: |
||||||||
Cost of revenues |
60,853 | 61,714 | ||||||
Selling, general and administrative expenses |
17,222 | 15,884 | ||||||
Depreciaton and amortization |
4,674 | 4,264 | ||||||
Acquisition related costs |
116 | 91 | ||||||
Total costs and expenses |
82,865 | 81,953 | ||||||
Income from operations |
34,691 | 30,358 | ||||||
Other income (expense): |
||||||||
Interest income |
52 | 189 | ||||||
Interest expense |
(2,529 | ) | (3,927 | ) | ||||
Debt extinguishments |
| (1,628 | ) | |||||
Other expense |
(420 | ) | (645 | ) | ||||
Total other income (expense) |
(2,897 | ) | (6,011 | ) | ||||
Income before income taxes |
31,794 | 24,347 | ||||||
Income tax expense |
12,670 | 9,666 | ||||||
Net income |
$ | 19,124 | $ | 14,681 | ||||
Earnings per share - Basic |
$ | 0.44 | $ | 0.36 | ||||
Earnings per share - Diluted |
$ | 0.42 | $ | 0.32 | ||||
Weighted average number of common shares outstanding Basic |
43,154,583 | 40,521,598 | ||||||
Weighted average number of common shares outstandingDiluted |
46,045,010 | 45,843,228 | ||||||
The accompanying notes are an integral part of these financial statements
4
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(unaudited)
For the Three Months Ended March 31, |
||||||||
2004 |
2003 |
|||||||
OPERATING ACTIVITIES: |
||||||||
Net income |
$ | 19,124 | $ | 14,681 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Stock compensation expense |
21 | 76 | ||||||
Write-off deferred financing fees |
| 247 | ||||||
Deferred tax expense |
(768 | ) | 3,555 | |||||
Tax benefit of disqualifying dispositions of stock options |
2,067 | 1,343 | ||||||
Loss on sale of fixed assets |
91 | 72 | ||||||
Depreciation |
4,070 | 3,943 | ||||||
Amortization |
604 | 321 | ||||||
Changes in operating assets and liabilities, net of effect of acquisitions: |
||||||||
Accounts receivable |
733 | (2,200 | ) | |||||
Parts and supplies |
298 | (279 | ) | |||||
Prepaid expenses and other assets |
4,319 | 5,626 | ||||||
Accounts payable |
(6,154 | ) | (2,643 | ) | ||||
Accrued liabilities |
1,163 | 3,368 | ||||||
Deferred revenue |
2,637 | 165 | ||||||
Net cash provided by operating activities |
28,205 | 28,275 | ||||||
INVESTING ACTIVITIES: |
||||||||
Payments for acquisitions and international investments, net of cash acquired |
(7,621 | ) | (31,301 | ) | ||||
Short-term investments |
307 | (629 | ) | |||||
Proceeds from sale of equipment |
253 | 132 | ||||||
Capital expenditures |
(5,347 | ) | (3,788 | ) | ||||
Net cash used in investing activities |
(12,408 | ) | (35,586 | ) | ||||
FINANCING ACTIVITIES: |
||||||||
Net proceeds from issuance of note payable |
618 | 1,132 | ||||||
Net repayments of senior credit facility |
(18,000 | ) | 15,814 | |||||
Repurchase of senior subordinated debt |
| (9,129 | ) | |||||
Repayment of long-term debt |
(949 | ) | (752 | ) | ||||
Purchase of commonn stock |
(4,294 | ) | | |||||
Payments of deferred financing costs |
| (395 | ) | |||||
Principal payments on capital lease obligations |
(259 | ) | (252 | ) | ||||
Proceeds from issuances of common stock |
3,240 | 1,733 | ||||||
Net cash provide by (used in) financing activities |
(19,644 | ) | 8,151 | |||||
Effect of exchange rate changes on cash |
(261 | ) | (27 | ) | ||||
Net increase (decrease) in cash and cash equivalents |
(4,108 | ) | 813 | |||||
Cash and cash equivalents at beginning of period |
7,240 | 8,375 | ||||||
Cash and cash equivalents at end of period |
$ | 3,132 | $ | 9,188 | ||||
Non-cash activities: |
||||||||
Net issuances of common stock for certain acquisitions |
$ | 70 | $ | 70 | ||||
Net issuances of notes payable for certain acquisitions |
$ | 5,000 | $ | |
The accompanying notes are an integral part of these financial statements
5
STERICYCLE, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2004
Unless the context requires otherwise, we, us or our refers to Stericycle, Inc. and its subsidiaries on a consolidated basis.
NOTE 1BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations; but the Company believes the disclosures in the accompanying condensed consolidated financial statements are adequate to make the information presented not misleading. In our opinion, all adjustments necessary for a fair presentation for the periods presented have been reflected and are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements and notes thereto for the year ended December 31, 2003, as filed with our Annual Report on Form 10-K for the year ended December 31, 2003. The results of operations for the three-month period ended March 31, 2004 are not necessarily indicative of the results that may be achieved for the entire year ending December 31, 2004.
NOTE 2ACQUISITIONS
During the quarter ended March 31, 2004 we completed the acquisition of selected assets from American Waste Industries, Inc., which operated in Virginia, Maryland and North Carolina. The purchase price was $12.6 million, of which $7.6 million was paid in cash and $5.0 million was paid by the issuance of a promissory note. The acquisition was not significant to our operations.
NOTE 3STOCK OPTIONS
During the quarter ended March 31, 2004, options to purchase 636,545 shares of common stock were granted to employees. These options vest ratably over a five-year period and have exercise prices of $44.22-$47.93 per share. In addition warrants to purchase 3,500 shares of common stock were granted to outside consultants. These warrants vest ratably over a five-year period and have an exercise price of $44.22.
6
Pro forma information regarding net income and net income per share is required by FAS 123 as if we had accounted for our employee stock options granted subsequent to December 31, 1994 under the fair value method of that statement. Options granted were valued using the Black-Scholes option-pricing model.
Option value models require the input of highly subjective assumptions. Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in managements opinion, the existing method does not necessarily provide a reliable single measure of the fair value of its employee stock options.
For purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the option-vesting period. Our pro forma information follows (in thousands, except for per share information):
Three Months Ended March 31, | ||||||
2004 |
2003 | |||||
As reported net income |
$ | 19,124 | $ | 14,681 | ||
Pro forma impact of stock options, net of tax |
1,017 | 2,061 | ||||
Pro forma net income |
$ | 18,107 | $ | 12,620 | ||
Earnings per share |
||||||
Basic-as reported |
$ | 0.44 | $ | 0.36 | ||
Basic-pro forma |
$ | 0.42 | $ | 0.31 | ||
Diluted-as reported |
$ | 0.42 | $ | 0.32 | ||
Diluted-pro forma |
$ | 0.40 | $ | 0.28 | ||
NOTE 4COMMON AND PREFERRED STOCK.
During the quarter ended March 31, 2004, options to purchase 277,835 shares of common stock were exercised at prices ranging from $4.00-$35.79 per share. During the quarter ended March 31, 2004, we repurchased and subsequently cancelled 100,000 shares of common stock. The average price to repurchase the shares was $42.93 per share.
During the quarter ended March 31, 2004 holders of Series A convertible preferred stock converted 10,451 shares into 1,300,000 shares of our common stock. As of March 31, 2004, there were 12,348 shares of Series A convertible preferred stock issued and outstanding. The preferred stock is convertible into 1,535,668 shares of common stock and in included in the denominator for the computation of diluted earnings per share.
7
NOTE 5NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per share:
STERICYCLE, INC. AND SUBSIDIARIES
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(unaudited)
Three Months Ended March 31, | ||||||
2004 |
2003 | |||||
Numerator: |
||||||
Numerator for basic earnings per share |
||||||
Net income |
$ | 19,124 | $ | 14,681 | ||
Denominator: |
||||||
Denominator for basic earnings per share |
||||||
Weighted average shares |
43,154,583 | 40,521,598 | ||||
Effect of dilutive securities: |
||||||
Employee stock options |
1,060,457 | 1,558,686 | ||||
Warrants |
8,587 | 115,276 | ||||
Convertible preferred stock |
1,821,383 | 3,647,668 | ||||
Dilutive potential shares |
2,890,427 | 5,321,630 | ||||
Denominator for diluted earnings per share adjusted weighted average shares after assumed conversions |
46,045,010 | 45,843,228 | ||||
Earnings per share - Basic |
$ | 0.44 | $ | 0.36 | ||
Earnings per share - Diluted |
$ | 0.42 | $ | 0.32 | ||
8
NOTE 6COMPREHENSIVE INCOME
The components of total comprehensive income are net income, change in cumulative currency translation adjustments and the change in cumulative unrealized losses on derivative instruments recorded in accordance with FAS 133. The following table details the total comprehensive income for the current and prior year periods.
Changes in Balance Sheet |
Total | ||||||||||||
Net Income |
Currency Translation |
Derivative Instruments |
Comprehensive Income | ||||||||||
Three months ended March 31, 2003 |
$ | 14,681 | $ | (24 | ) | $ | 232 | $ | 14,889 | ||||
Three months ended March 31, 2004 |
19,124 | (194 | ) | 0 | 18,930 |
NOTE 7 GOODWILL AND OTHER INTANGIBLES
We have two geographical reporting segments, United States and Foreign Countries, both of which have goodwill. The changes in the carrying amount of goodwill for the three months ended March 31, 2004, was as follows (in thousands):
United States |
Foreign Countries |
Total |
|||||||||
Balance as of January 1, 2004 |
$ | 458,593 | $ | 6,353 | $ | 464,946 | |||||
Change due to currency fluctuation |
0 | 650 | 650 | ||||||||
Allocated to intangibles during year |
(1,200 | ) | (1,200 | ) | |||||||
Goodwill acquired during year |
12,000 | 0 | 12,000 | ||||||||
Balance as of March 31, 2004 |
$ | 469,393 | $ | 7,003 | $ | 476,396 | |||||
According to FAS 142, other intangible assets will continue to be amortized over their useful lives. During the quarter ended March 31, 2004, we recorded at fair value the intangibles acquired in connection with our acquisitions of Pharmacy Software Solutions, Inc., in December 2003, which previously had been included in goodwill. At March 31, 2004, we had $12.7 million in the goodwill account related the American Waste Industries, Inc. acquisition that we recently completed in which the assignment of intangibles and goodwill had not yet been determined.
NOTE 8-NON-CONSOLIDATING JOINT VENTURES
During the quarter ended March 31, 2004 we sold our minority interest investment in Evertrade Medical Waste (Pty) Ltd, a South African joint venture and the associated current receivables and loans due from the joint venture. No gain or loss was recognized on the disposition of these assets.
NOTE 9NEW ACCOUNTING STANDARDS
In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, and Interpretation of Accounting Research Bulletin (ARB) No. 51 (the Interpretation). The Interpretation introduced a new consolidation model, which determines control, and consolidation based on potential variability in gains and losses of the entity being evaluated for consolidation. The adoption of the Interpretation did not have an impact on our consolidated financial statements.
9
NOTE 10-GUARANTEES
During the quarter ended March 31, 2004, we agreed to provide a guarantee in the amount of $10.0 million to a Japanese bank on behalf of one of our Japanese customers. This guarantee is for a period of five years and the amount will be reduced as the customer repays its loan to the bank.
NOTE 11LEGAL PROCEEDINGS
We operate in a highly regulated industry and are must deal with regulatory inquiries or investigations from time to time. Government authorities can initiate investigations for a variety of reasons. We have been involved in several legal and administrative proceedings that have been settled or otherwise resolved on terms acceptable to us, without having a material adverse effect on our business.
In January 2003, we were sued in federal court in Arizona by a private plaintiff claiming anticompetitive conduct in Arizona, Colorado and Utah from November 1997 to the present and seeking certification of the lawsuit as a class action on behalf of all customers of ours and of Browning-Ferris Industries, Inc. in the three-state area during the period in question. Over the next three months, four similar suits were filed in federal court in Utah, Arizona, Colorado and New Mexico. In February and May 2003, two additional suits were filed, in federal court in Utah and Arizona, claiming substantially the same anticompetitive conduct but not seeking class action certification. In December 2003, an eighth suit was filed in federal court in Utah claiming monopolistic and other anticompetitive conduct in California during the prior four years and seeking certification of the suit as a class action on behalf of all California customers of ours during this four-year period. These eight suits have now been consolidated before the same judge in federal court in Utah. The first five suits have been consolidated under one consolidated class action complaint; the next two suits have been consolidated for discovery purposes; and the eighth suit has been coordinated for discovery purposes. We believe that none of these eight suits has any merit.
We and four of our officers and directors are parties to a suit filed in state court in Louisiana in July 2002 by a shareholder of our majority-owned subsidiary, 3CI Complete Compliance Corporation (3CI). This suit, which was filed on behalf of the minority shareholders of 3CI and derivatively on behalf of 3CI itself, alleges, among other claims, that we and the four directors of 3CI who are serving as our designees (and who are also officers or directors of ours) unjustly enriched Stericycle at the expense of 3CI and its other shareholders. The plaintiff seeks, among other relief, damages and an order requiring the buyout of 3CIs minority shareholders. In October 2003, the plaintiffs filed an amended complaint adding 3CI as a derivative defendant. This suit is still at a very early stage, with the parties currently conducting preliminary discovery. We believe that the plaintiffs claims are without merit.
In May 2003, 3CI, at the direction of its independent directors, filed a declaratory judgment action in state court in Texas to resolve a disagreement with us over the proper rate of conversion of the shares of 3CIs preferred stock held by our wholly-owned subsidiary, Waste Systems, Inc. (WSI). In August 2003, this action was dismissed by the court on procedural grounds, and 3CI refiled its action as a new suit.
10
In October 2003, the plaintiff in the Louisiana lawsuit and others answered or intervened in 3CIs Texas lawsuit, naming us as a third-party defendant and making substantially the same claims alleged in the Louisiana lawsuit. We and WSI have denied these claims, and believe that they are without merit.
In September 2003, the full board of 3CI appointed a special committee consisting of 3CIs three independent directors to act on 3CIs behalf in respect of the dispute with us and WSI regarding the conversion rate of 3CIs preferred stock. In January 2004, the full board expanded the special committees authority to include an investigation of all claims by the plaintiff in the Louisiana lawsuit and by the third-party plaintiffs in the Texas lawsuit, and to act on 3CIs behalf in respect of both lawsuits.
NOTE 12CONDENSED CONSOLIDATING FINANCIAL INFORMATION
Payments under our senior subordinated notes (the Notes) are unconditionally guaranteed, jointly and severally, by certain of our 100% owned domestic subsidiaries (collectively, the Guarantors). Financial information concerning the Guarantors as of March 31, 2004 and December 31, 2003 and for the three month periods ended March 31, 2004 and 2003 is presented below for purposes of complying with the reporting requirements of the Guarantor subsidiaries. The financial information concerning the Guarantors is being presented through condensed consolidating financial statements since we have more than minimal independent operations and the guarantees are full and unconditional and are joint and several. Financial statements for the Guarantors have not been presented because management does not believe that such financial statements are material to investors.
11
CONDENSED CONSOLIDATING BALANCE SHEET
MARCH 31, 2004
UNAUDITED
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED | ||||||||||||||
ASSETS |
|||||||||||||||||||
Current assets: |
|||||||||||||||||||
Cash and cash equivalents |
$ | 1,132 | $ | | $ | 1,132 | $ | 2,000 | $ | | $ | 3,132 | |||||||
Other current assets |
75,351 | 20,663 | 96,014 | 8,636 | (23,392 | ) | 81,258 | ||||||||||||
Total current assets |
76,483 | 20,663 | 97,146 | 10,636 | (23,392 | ) | 84,390 | ||||||||||||
Property, plant and equipment, net |
88,025 | 9 | 88,034 | 9,595 | | 97,629 | |||||||||||||
Goodwill, net |
463,230 | 1,573 | 464,803 | 11,593 | | 476,396 | |||||||||||||
Investment in subsidiaries |
42,531 | 2,961 | 45,492 | | (45,492 | ) | | ||||||||||||
Other assets |
49,513 | 1,009 | 50,522 | 1,821 | (3,113 | ) | 49,230 | ||||||||||||
Total assets |
$ | 719,782 | $ | 26,215 | $ | 745,997 | $ | 33,645 | $ | (71,997 | ) | $ | 707,645 | ||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
|||||||||||||||||||
Current liabilities: |
|||||||||||||||||||
Current portion of long-term debt |
$ | 4,696 | $ | | $ | 4,696 | $ | 636 | $ | | $ | 5,332 | |||||||
Other current liabilities |
78,622 | | 78,622 | 6,580 | (23,392 | ) | 61,810 | ||||||||||||
Total current liabilities |
83,318 | | 83,318 | 7,216 | (23,392 | ) | 67,142 | ||||||||||||
Long-term debt, net of current portion |
147,030 | | 147,030 | 5,007 | (3,113 | ) | 148,924 | ||||||||||||
Other liabilities |
40,636 | | 40,636 | 2,145 | | 42,781 | |||||||||||||
Redeemable preferred stock |
9,569 | | 9,569 | | | 9,569 | |||||||||||||
Common shareholders equity |
439,229 | 26,215 | 465,444 | 19,277 | (45,492 | ) | 439,229 | ||||||||||||
Total liabilities and shareholders equity |
$ | 719,782 | $ | 26,215 | $ | 745,997 | $ | 33,645 | $ | (71,997 | ) | $ | 707,645 | ||||||
12
CONDENSED CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2003
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED | ||||||||||||||
ASSETS |
|||||||||||||||||||
Current assets: |
|||||||||||||||||||
Cash and cash equivalents |
$ | 5,766 | $ | | $ | 5,766 | $ | 1,474 | $ | | $ | 7,240 | |||||||
Other current assets |
84,300 | 19,738 | 104,038 | 8,620 | (22,161 | ) | 90,497 | ||||||||||||
Total current assets |
90,066 | 19,738 | 109,804 | 10,094 | (22,161 | ) | 97,737 | ||||||||||||
Property, plant and equipment, net |
86,769 | 10 | 86,779 | 9,783 | | 96,562 | |||||||||||||
Goodwill, net |
447,485 | 5,226 | 452,711 | 12,235 | | 464,946 | |||||||||||||
Investment in subsidiaries |
45,223 | 829 | 46,052 | | (46,052 | ) | | ||||||||||||
Other assets |
49,009 | 3,221 | 52,230 | 1,731 | (5,744 | ) | 48,217 | ||||||||||||
Total assets |
$ | 718,552 | $ | 29,024 | $ | 747,576 | $ | 33,843 | $ | (73,957 | ) | $ | 707,462 | ||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
|||||||||||||||||||
Current liabilities: |
|||||||||||||||||||
Current portion of long-term debt |
$ | 4,819 | $ | | $ | 4,819 | $ | 11 | $ | | $ | 4,830 | |||||||
Other current liabilities |
79,079 | | 79,079 | 7,246 | (22,161 | ) | 64,164 | ||||||||||||
Total current liabilities |
83,898 | | 83,898 | 7,257 | (22,161 | ) | 68,994 | ||||||||||||
Long-term debt, net of current portion |
160,794 | | 160,794 | 7,966 | (5,744 | ) | 163,016 | ||||||||||||
Other liabilities |
45,096 | | 45,096 | 1,592 | | 46,688 | |||||||||||||
Redeemable preferred stock |
20,944 | | 20,944 | | | 20,944 | |||||||||||||
Common shareholders equity |
407,820 | 29,024 | 436,844 | 17,028 | (46,052 | ) | 407,820 | ||||||||||||
Total liabilities and shareholders equity |
$ | 718,552 | $ | 29,024 | $ | 747,576 | $ | 33,843 | $ | (73,957 | ) | $ | 707,462 | ||||||
13
CONDENSED CONSOLIDATING STATEMENT OF INCOME
THREE MONTHS ENDED MARCH 31, 2004
UNAUDITED
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED |
|||||||||||||||||||
Revenues |
$ | 109,468 | $ | 331 | $ | 109,799 | $ | 8,376 | $ | (619 | ) | $ | 117,556 | |||||||||||
Cost of revenues |
59,275 | 164 | 59,439 | 5,581 | (619 | ) | 64,401 | |||||||||||||||||
Selling, general, and administrative expenses |
15,916 | 145 | 16,061 | 2,287 | | 18,348 | ||||||||||||||||||
Acquisition related costs |
116 | | 116 | | | 116 | ||||||||||||||||||
Total costs and expenses |
75,307 | 309 | 75,616 | 7,868 | (619 | ) | 82,865 | |||||||||||||||||
Income from operations |
34,161 | 22 | 34,183 | 508 | | 34,691 | ||||||||||||||||||
Equity in net income of subsidiaries |
245 | (194 | ) | 51 | | (51 | ) | | ||||||||||||||||
Other (expense) income, net |
(2,613 | ) | 16 | (2,597 | ) | (300 | ) | | (2,897 | ) | ||||||||||||||
Income before income taxes |
31,793 | (156 | ) | 31,637 | 208 | (51 | ) | 31,794 | ||||||||||||||||
Income tax expense (benefit) |
12,669 | 7 | 12,676 | (6 | ) | | 12,670 | |||||||||||||||||
Net income (loss) |
$ | 19,124 | $ | (163 | ) | $ | 18,961 | $ | 214 | $ | (51 | ) | $ | 19,124 | ||||||||||
CONDENSED CONSOLIDATING STATEMENT OF INCOME
THREE MONTHS ENDED MARCH 31, 2003
UNAUDITED
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED |
||||||||||||||||||
Revenues |
$ | 99,184 | $ | 5,289 | $ | 104,473 | $ | 8,601 | $ | (763 | ) | $ | 112,311 | ||||||||||
Cost of revenues |
56,104 | 3,724 | 59,828 | 6,078 | (739 | ) | 65,167 | ||||||||||||||||
Selling, general, and administrative expenses |
13,881 | 1,059 | 14,940 | 1,755 | | 16,695 | |||||||||||||||||
Acquisition related costs |
91 | | 91 | | | 91 | |||||||||||||||||
Total costs and expenses |
70,076 | 4,783 | 74,859 | 7,833 | (739 | ) | 81,953 | ||||||||||||||||
Income from operations |
29,108 | 506 | 29,614 | 768 | (24 | ) | 30,358 | ||||||||||||||||
Equity in net income of subsidiaries |
1,004 | 17 | 1,021 | | (1,021 | ) | | ||||||||||||||||
Other (expense) income, net |
(5,854 | ) | 53 | (5,801 | ) | (234 | ) | 24 | (6,011 | ) | |||||||||||||
Income before income taxes |
24,258 | 576 | 24,834 | 534 | (1,021 | ) | 24,347 | ||||||||||||||||
Income tax expense (benefit) |
9,577 | 204 | 9,781 | (115 | ) | | 9,666 | ||||||||||||||||
Net income (loss) |
$ | 14,681 | $ | 372 | $ | 15,053 | $ | 649 | $ | (1,021 | ) | $ | 14,681 | ||||||||||
14
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
THREE MONTHS ENDED MARCH 31, 2004
UNAUDITED
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED |
|||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||||||||||||||||
Net cash provided by operating activities |
$ | 27,369 | $ | | $ | 27,369 | $ | 836 | $ | | $ | 28,205 | ||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||||||||||||||||
Capital expenditures |
(4,898 | ) | | (4,898 | ) | (449 | ) | | (5,347 | ) | ||||||||||||
Payments for acquisitions and international investments, net of cash acquired |
(7,593 | ) | | (7,593 | ) | (28 | ) | | (7,621 | ) | ||||||||||||
Proceeds from sale of equipment |
251 | | 251 | 2 | | 253 | ||||||||||||||||
Short-term investments |
178 | | 178 | 129 | | 307 | ||||||||||||||||
Net cash used in investing activities |
(12,062 | ) | | (12,062 | ) | (346 | ) | | (12,408 | ) | ||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||||||||||||||||
Net repayments of senior credit facility |
(18,000 | ) | | (18,000 | ) | | | (18,000 | ) | |||||||||||||
Principal payments on capital lease obligations |
(256 | ) | | (256 | ) | (3 | ) | | (259 | ) | ||||||||||||
Repayment of long term debt |
(631 | ) | | (631 | ) | (318 | ) | | (949 | ) | ||||||||||||
Purchase of treasury stock |
(4,294 | ) | | (4,294 | ) | | | (4,294 | ) | |||||||||||||
Net proceeds from issuance of notes payable |
| | | 618 | | 618 | ||||||||||||||||
Proceeds from issuance of common stock |
3,240 | | 3,240 | | | 3,240 | ||||||||||||||||
Net cash provided by (used in) financing activity |
(19,941 | ) | | (19,941 | ) | 297 | | (19,644 | ) | |||||||||||||
Effect of exchange rate changes on cash |
| | | (261 | ) | | (261 | ) | ||||||||||||||
Net (decrease) increase in cash and cash equivalents |
$ | (4,634 | ) | $ | | $ | (4,634 | ) | $ | 526 | $ | | (4,108 | ) | ||||||||
Cash and cash equivalents at beginning of period |
7,240 | |||||||||||||||||||||
Cash and cash equivalents at end of period |
$ | 3,132 | ||||||||||||||||||||
15
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
THREE MONTHS ENDED MARCH 31, 2003
UNAUDITED
STERICYCLE, INC. |
GUARANTOR SUBSIDIARIES |
COMBINED STERICYCLE AND GUARANTOR SUBSIDIARIES |
NON-GUARANTOR SUBSIDIARIES |
ELIMINATIONS |
CONSOLIDATED |
||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|||||||||||||||||||||||
Net cash provided by operating activities |
$ | 27,041 | $ | 622 | $ | 27,663 | $ | 612 | $ | | $ | 28,275 | |||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|||||||||||||||||||||||
Capital expenditures |
(3,109 | ) | (183 | ) | (3,292 | ) | (496 | ) | | (3,788 | ) | ||||||||||||
Proceeds from sale of equipment |
132 | | 132 | | | 132 | |||||||||||||||||
cash acquired |
| | | | | | |||||||||||||||||
Payments for acquisitions and international investments, net of cash acquired |
(2,601 | ) | (28,700 | ) | (31,301 | ) | | | (31,301 | ) | |||||||||||||
Short-term investments |
| | | (629 | ) | | (629 | ) | |||||||||||||||
Net cash used in investing activities |
(5,578 | ) | (28,883 | ) | (34,461 | ) | (1,125 | ) | | (35,586 | ) | ||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|||||||||||||||||||||||
Net borrowings on senior credit facility |
15,814 | | 15,814 | | | 15,814 | |||||||||||||||||
Principal payments on capital lease obligations |
(274 | ) | (46 | ) | (320 | ) | 68 | | (252 | ) | |||||||||||||
Net proceeds from issuance of notes payable |
| | | 1,132 | | 1,132 | |||||||||||||||||
Repayments on long-term debt |
(706 | ) | | (706 | ) | (46 | ) | | (752 | ) | |||||||||||||
Payments of deferred financing costs |
(395 | ) | | (395 | ) | | | (395 | ) | ||||||||||||||
Repurchase of senior subordinated debt |
(9,129 | ) | | (9,129 | ) | | | (9,129 | ) | ||||||||||||||
Proceeds from issuance of common stock |
1,733 | | 1,733 | | | 1,733 | |||||||||||||||||
Intercompany financing of acquisitions |
(28,700 | ) | 28,700 | | | | | ||||||||||||||||
Net cash provided by (used in) financing activity |
(21,657 | ) | 28,654 | 6,997 | 1,154 | | 8,151 | ||||||||||||||||
Effect of exchange rate changes on cash |
| | | (27 | ) | | (27 | ) | |||||||||||||||
Net (decrease) increase in cash and cash equivalents |
$ | (194 | ) | $ | 393 | $ | 199 | $ | 614 | $ |
|
813 | |||||||||||
Cash and cash equivalents at beginning of period |
8,375 | ||||||||||||||||||||||
Cash and cash equivalents at end of period |
$ | 9,188 | |||||||||||||||||||||
16
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
We were incorporated in March 1989. We provide compliance services including regulated medical waste collection, transportation and treatment services to our customers and related training and education programs and consulting services. We also sell ancillary supplies and transport pharmaceuticals, photographic chemicals, lead foil and amalgam for recycling in selected geographic service areas. We are also expanding into international markets through joint ventures and/or by licensing our proprietary technology and selling associated equipment.
THREE MONTHS ENDED MARCH 31, 2004 COMPARED TO THREE MONTHS ENDED MARCH 31, 2003
The following summarizes (in thousands) the Companys operations:
Three Months Ended March 31, | ||||||||||
2004 |
2003 | |||||||||
$ |
% |
$ |
% | |||||||
Revenues |
$ | 117,556 | 100.0 | $ | 112,311 | 100.0 | ||||
Cost of revenues |
60,853 | 51.8 | 61,714 | 54.9 | ||||||
Depreciation |
3,548 | 3.0 | 3,453 | 3.1 | ||||||
Total cost of revenues |
64,401 | 54.8 | 65,167 | 58.0 | ||||||
Gross profit |
53,155 | 45.2 | 47,144 | 42.0 | ||||||
Selling, general and administrative expenses |
17,222 | 14.7 | 15,884 | 14.1 | ||||||
Depreciation |
522 | 0.4 | 490 | 0.4 | ||||||
Amortization |
604 | 0.5 | 321 | 0.3 | ||||||
Acquisition related costs |
116 | 0.1 | 91 | 0.1 | ||||||
Total selling, general and administrative expenses |
18,464 | 15.7 | 16,786 | 14.9 | ||||||
Income from operations |
34,691 | 29.5 | 30,358 | 27.0 | ||||||
Net income |
19,124 | 16.3 | 14,681 | 13.1 | ||||||
Earnings per share-diluted |
$ | 0.42 | $ | 0.32 |
Revenues. Revenues increased $5.3 million, or 4.7%, to $117.6 million during the quarter ended March 31, 2004 from $112.3 million during the comparable quarter in 2003 as a result of our continued strategy of focusing on sales to higher-margin small quantity customers. International equipment related revenues were $3.0 million during the quarter as compared to $0.7 million during the comparable quarter in 2003. During the quarter ended March 31, 2004, acquisitions less than one year old contributed approximately $1.6 million to the increase in our revenues from 2003. For the quarter, our base internal revenue growth for small quantity customers increased approximately 9.0% while revenues from large quantity customers decreased by approximately 7.2% because of our winnowing of lower-margin accounts.
The size of the regulated medical waste market in the United States remained relatively stable during the quarter.
17
Cost of revenues. Cost of revenues decreased slightly by $0.8 million to $64.4 million during the quarter ended March 31, 2004 from $65.2 million during the comparable quarter in 2003. Our gross margin percentage increased to 45.2% during the quarter from 42.0% during the same quarter in 2003 as we continued to realize improvements from our ongoing programs to improve the margins on our large quantity business and increased our number of small quantity customers electing our Steri-SafeSM program from 55,000 to 75,000. In addition we were able to improve our transportation productivity by increasing our route density. These improvements to our gross margins were partially offset by an increase of 20 basis points in energy costs in 2003.
Selling, general and administrative expenses. Selling, general and administrative expenses, including acquisition related costs, increased to $18.4 million for the quarter ended March 31, 2004 from $16.8 million for the comparable quarter in 2003. The increase was the result of higher spending related to strategic marketing programs such as BioSystems, Steri-SafeSM and our other new initiatives, partially offset by lower bad debt expense. Amortization expense increased to $0.6 million during the quarter from $0.3 million in the same quarter in 2003. This increase was the result of intangibles identified relative to acquisitions completed throughout 2003. Selling, general and administrative expenses as a percent of revenues increased to 15.6% during the quarter from 14.9% during the comparable quarter in 2003.
Income from operations. Income from operations increased to $34.7 million for the quarter ended March 31, 2004 from $30.4 million for the comparable quarter in 2003. The increase was due to higher gross profit margins, partially offset by higher selling, general and administrative expenses during the quarter. Income from operations as a percentage of revenue increased to 29.5% during the quarter from 27.0% during the same quarter in 2003 as a result of the factors described above.
Net interest expense. Net interest expense decreased to $2.5 million during the quarter ended March 31, 2004 from $3.7 million during the comparable quarter in 2003 primarily due to reduced debt and modestly lower interest rates.
Debt extinguishments. We did not repurchase any of our 12 3/8% senior subordinated notes in the quarter ended March 31, 2004. During the same period in 2003 we incurred a $1.6 million expense related to the repurchase of $9.1 million of these notes.
Income tax expense. Income tax expense increased to $12.7 million for the quarter ended March 31, 2004 from $9.7 million for the comparable quarter in 2003. The increase was due to higher taxable income and a higher effective tax rate. The effective tax rates for the quarters ended March 31, 2004 and 2003 were 39.9% and 39.7%, respectively.
LIQUIDITY AND CAPITAL RESOURCES
Our credit facility requires us to comply with various financial, reporting and other covenants and restrictions, including a restriction on dividend payments. At March 31, 2004 we were in compliance with all of our financial debt covenants. As of March 31, 2004, we had $91.7 million of borrowings outstanding under our senior secured credit facility, consisting of $2.0 million under our revolving credit facility, $62.4 million under our Term A loan facility and $27.3 million under our Term B loan facility.
18
Working Capital. At March 31, 2004, our working capital was $17.2 million compared to working capital of $27.3 million at December 31, 2003. The decrease in working capital was primarily due to lower deferred tax asset, prepaid expenses, cash and other current asset balances partially offset by lower accounts payable and accrued liability balances. At March 31, 2004, we had available a $105.0 million revolving line of credit under our senior secured credit facility which was secured by our accounts receivable and all of our others assets. At March 31, 2004 we had borrowed $2.0 million and had committed $17.6 million as letters of credit under the line.
Net Cash Provided or Used. Net cash provided by operating activities was $28.2 million during the three months ended March 31, 2004 compared to $28.3 million for the comparable period in 2003. This decrease primarily reflects decreased accounts payable and accrued liability balances partially offset by higher net income and deferred revenue balances. Net cash provided by operating activities during the 2004 quarter included a $2.1 million tax benefit from disqualifying dispositions of stock acquired upon the exercise of incentive stock options, compared to a $1.3 million tax benefit during the comparable quarter in 2003.
Net cash used in investing activities for the three months ended March 31, 2004 was $12.4 million compared to $35.6 million for the comparable period in 2003. This decrease is primarily attributable to the Scherer Healthcare, Inc. acquisition, which occurred during the 2003 quarter. Cash investments in acquisitions and international joint ventures for the three months ended March 31, 2004 were $7.6 million versus $31.3 million in the comparable period in 2003. Capital expenditures were $5.3 million for the quarter compared to $3.8 million during the same period in 2003.
At March 31, 2004 we had approximately 12% of our treatment capacity in incineration and approximately 88% in non-incineration technologies such as our proprietary patented ETD technology and autoclaving. We intend to reduce the incineration portion, as customers preferences, regulations and business circumstances permit. The implementation of our commitment to move away from incineration may result in a write-down of the incineration equipment as and when we close incinerators that we are currently operating. Our commitment to move away from incineration is in the nature of a goal to be accomplished over an indeterminate number of years. Because of uncertainties relating, among other things, to customer education and acceptance and legal requirements to incinerate portions of the medical waste, we do not have a timetable for this transition. However, during the second quarter of 2004 we will begin the process of converting our Baltimore, MD incinerator to an autoclave and will close our Terrell, TX incinerator. We anticipate that we will write-off approximately $1.0 million in related equipment once it becomes idle.
Net cash used in financing activities was $19.6 million during the three months ended March 31, 2004 compared to net cash provided by financing activities of $8.2 million for the comparable period in 2003. During the period in 2004 we made net repayments of $19.2 million in debt and capital leases which consisted of $1.2 million in scheduled payments and $18.0 million in prepayments.
In addition during the three month period ended March 31, 2004 we issued a $5.0 million promissory note in connection with the American Waste Industries, Inc. acquisition.
19
ITEM 3QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK
We are subject to market risks arising from changes in interest rates on our senior secured credit facility. Our interest rate exposure results from changes in LIBOR or the base rate which are used to determine the applicable interest rates under our term loans and revolving credit facility. Our potential loss over one year that would result from a hypothetical, instantaneous and unfavorable change of 100 basis points in the interest rate on all of our variable rate obligations would be approximately $0.9 million. Fluctuations in interest rates will not affect the interest payable on our senior subordinated notes, which is fixed.
We have exposure to commodity pricing for gas and diesel fuel for our trucks. We do not hedge these items to manage the exposure.
ITEM 4CONTROLS AND PROCEDURES
Our management, with the participation of our President and Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter covered by this Report. On the basis of this evaluation, our President and Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure controls and procedures were effective.
The term disclosure controls and procedures is defined in Rule 13a-14(e) of the Securities Exchange Act of 1934 as controls and other procedures designed to ensure that information required to be disclosed by the issuer in the reports, files or submits under the Act is recorded, processed, summarized and reported, within the time periods specified in the [Securities and Exchange] Commissions rules and forms. Our disclosure controls and procedures are designed to ensure that material information relating to us and our consolidated subsidiaries is accumulated and communicated to our management, including our President and Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding our required disclosures.
FROM TIME TO TIME WE ISSUE FORWARD-LOOKING STATEMENTS RELATING TO SUCH THINGS AS ANTICIPATED FINANCIAL PERFORMANCE, BUSINESS PROSPECTS, ACQUISITION ACTIVITIES AND SIMILAR MATTERS.
THESE FORWARD-LOOKING STATEMENTS MAY INVOLVE RISKS AND UNCERTAINTIES, SOME OF WHICH ARE BEYOND OUR CONTROL (FOR EXAMPLE, GENERAL ECONOMIC CONDITIONS). OUR ACTUAL RESULTS COULD DIFFER SIGNIFICANTLY FROM THE RESULTS DESCRIBED IN THE FORWARD-LOOKING STATEMENTS. FACTORS THAT COULD CAUSE SUCH DIFFERENCES INCLUDE DIFFICULTIES IN COMPLETING THE INTEGRATION OF ACQUIRED BUSINESSES, CHANGES IN GOVERNMENTAL REGULATION OF MEDICAL WASTE COLLECTION AND TREATMENT, AND INCREASES IN TRANSPORTATION AND OTHER OPERATING COSTS, AS WELL AS VARIOUS OTHER FACTORS.
20
See Note 11, Legal Proceedings, in the Notes to the Condensed Consolidated Financial Statements (Item 1 of Part 1).
ITEM 2. CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES
The following table provides information about our purchases during the quarter ended March 31, 2004 of shares of our common stock.
Issuer Purchases of Equity Securities
Period |
Total Number of Shares (or Units) Purchased |
Average Price Paid per Share (or Unit) |
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |
Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs | ||||
January 1-January 31, 2004 |
100,000 | 42.94 | 100,000 | 2,557,170 | ||||
February 1-February 29, 2004 |
0 | 0 | 0 | 2,557,170 | ||||
March 1-March 31, 2004 |
0 | 0 | 0 | 2,557,170 |
The shares were repurchased as part of the plan announced on May 16, 2002, authorizing the repurchase of up to 3,000,000 shares of our common stock. The plan does not have an expiration date.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) | Exhibits |
31.1 | Rule 13a-14(a)/15d-14(a) Certification of Mark C. Miller, President and Chief Executive Officer |
31.2 | Rule 13a-14(a)/15d-14(a) Certification of Frank J.M. ten Brink, Executive Vice President and Chief Financial Officer |
32 | Section 1350 Certification of Mark C. Miller, President and Chief Executive Officer, and Frank J.M. ten Brink, Executive Vice President and Chief Financial Officer |
21
(b) | Reports on Form 8-K |
During the quarter ended March 31, 2004, we filed one current report on Form 8-K.
We filed a Form 8-K on February 10, 2004 to report our earnings release on the same day. The report included as an exhibit our earnings release and accompanying financial statements.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: May 3, 2004.
STERICYCLE, INC. | ||
(Registrant) | ||
By: |
/s/ Frank J.M. ten Brink | |
Frank J.M. ten Brink | ||
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
22